Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Failed Prior Chemotherapy”

43 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 43 results

Testing effectiveness (Phase 2)Study completedNCT00895310
What this trial is testing

Use of Low Dose Ketoconazole in Prostate Cancer That Does Not Respond to Hormone Therapy and Prior Chemotherapy

Who this might be right for
Prostate Cancer
University of California, Davis 30
Testing effectiveness (Phase 2)Study completedNCT00072631
What this trial is testing

Erlotinib (Tarceva (Trademark), OSI-774) in Treating Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Advanced Non Small Cell Lung CancerFailed Prior Chemotherapy
OSI Pharmaceuticals 43
Testing effectiveness (Phase 2)Study completedNCT00745875
What this trial is testing

ZD4054 (Zibotentan) Phase II Non-Small Cell Lung Cancer Study

Who this might be right for
Non Small Cell Lung CancerLung Cancer
AstraZeneca 66
Testing effectiveness (Phase 2)Looking for participantsNCT07367516
What this trial is testing

Clinical Trial Evaluating TQB6411 Injection in Participant s With Esophageal Cancer

Who this might be right for
Esophageal Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 105
Not applicableNo Longer AvailableNCT02570412
What this trial is testing

Compassionate Use of Aldoxorubicin in Sarcoma Patients Chemotherapy

Who this might be right for
Sarcoma
CytRx
Testing effectiveness (Phase 2)UnknownNCT04872634
What this trial is testing

Evaluate the Safety and Anti-tumor Activity of SNK01 (NK Cells) Administered in Combination With Chemotherapy or Chemotherapy / Cetuximab in Local Advanced or Metastatic Non-small Cell Lung Cancer Patients Who Failed Tyrosine Kinase Inhibitor Treatment

Who this might be right for
Non-small Cell Lung Cancer
NKMAX Co., Ltd. 24
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06892431
What this trial is testing

JMT101 Combined With Mitoxantrone Liposome for Nasopharyngeal Cancer

Who this might be right for
Recurrent or Metastatic Nasopharyngeal CancerPatients Who Have Experienced Treatment Failure at Least Second-line Chemotherapy
Shanghai JMT-Bio Inc. 150
Testing effectiveness (Phase 2)UnknownNCT00021008
What this trial is testing

ZD0473 in Treating Patients With Progressive or Relapsed Non-Small Lung Cancer

Who this might be right for
Lung Cancer
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)WithdrawnNCT04751955
What this trial is testing

A Phase lb/ll, Open Label, Single Arm Study With Olinvacimab and Capecitabine in mCRC Patients (OLCAP)

Who this might be right for
Colorectal Cancer Metastatic
Korean Cancer Study Group
Large-scale testing (Phase 3)Active Not RecruitingNCT04639986
What this trial is testing

Asian Study of Sacituzumab Govitecan (IMMU-132) in HR+/HER2- Metastatic Breast Cancer (MBC)

Who this might be right for
Metastatic Breast Cancer
Gilead Sciences 331
Large-scale testing (Phase 3)Active Not RecruitingNCT06629597
What this trial is testing

A Phase III Study of YL201 in Recurrent or Metastatic Nasopharyngeal Carcinoma (TAISHAN-301)

Who this might be right for
Nasopharyngeal Carcinoma
MediLink Therapeutics (Suzhou) Co., Ltd. 400
Early research (Phase 1)Ended earlyNCT02258607
What this trial is testing

Efficacy and Safety of Momelotinib Combined With Trametinib in Adults With Metastatic KRAS-mutated Non-Small Cell Lung Cancer (NSCLC) Who Have Failed Platinum-Based Chemotherapy Preceded by a Dose-finding Lead-in Phase

Who this might be right for
Relapsed Metastatic KRAS-Mutated Non-Small Cell Lung Cancer
Sierra Oncology LLC - a GSK company 21
Large-scale testing (Phase 3)Not Yet RecruitingNCT07803783
What this trial is testing

Compare the Efficacy and Safety of YL201 With Standard Chemotherapy in Patients With Metastatic Pancreatic Cancer After Failure of Gemcitabine-Based Systemic Chemotherapy

Who this might be right for
Metastatic Pancreatic CancerPancreatic Ductal Adenocarcinoma (PDAC)
MediLink Therapeutics (Suzhou) Co., Ltd. 320
Large-scale testing (Phase 3)Study completedNCT00078260
What this trial is testing

A Comparison of Two Doses of Pemetrexed in Patients Who Have Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Eli Lilly and Company 589
Testing effectiveness (Phase 2)Study completedNCT01948141
What this trial is testing

Nintedanib in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Failed Up to Two Previous Chemotherapy Regimens

Who this might be right for
Recurrent Non-small Cell Lung CancerSquamous Cell Lung CancerStage III Non-small Cell Lung Cancer+1 more
Roswell Park Cancer Institute 6
Testing effectiveness (Phase 2)Study completedNCT00365547
What this trial is testing

Topotecan and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Did Not Respond to Previous Systemic Chemotherapy

Who this might be right for
Lung Cancer
Masonic Cancer Center, University of Minnesota 46
Testing effectiveness (Phase 2)Study completedNCT00419159
What this trial is testing

Efficacy and Safety of Everolimus in Patients With Metastatic Colorectal Cancer Who Have Failed Prior Targeted Therapy and Chemotherapy

Who this might be right for
Colorectal Cancer
Novartis Pharmaceuticals 199
Testing effectiveness (Phase 2)UnknownNCT04753203
What this trial is testing

Alpelisib and Capecitabine in Patients With PIK3CA Mutant mCRC Patients

Who this might be right for
Metastatic Colorectal CancerPIK3CA Gene Mutation
Korean Cancer Study Group 65
Early research (Phase 1)Study completedNCT00972036
What this trial is testing

Selective Internal Radiation Therapy (SIRT) in Patients With Unresectable Colorectal Cancer Liver Metastases Who Failed Prior Intraarterial Pump Chemotherapy

Who this might be right for
Colon CancerRectal Cancer
Memorial Sloan Kettering Cancer Center 32
Testing effectiveness (Phase 2)UnknownNCT00509964
What this trial is testing

Second-Line Irinotecan vs. ILF for AGC

Who this might be right for
Stomach NeoplasmMetastaticSecond-Line
Gachon University Gil Medical Center 50
Next Page